Sandra Sanabria

764 total citations
30 papers, 456 citations indexed

About

Sandra Sanabria is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra Sanabria has authored 30 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra Sanabria's work include Medical Imaging Techniques and Applications (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Advanced Breast Cancer Therapies (3 papers). Sandra Sanabria is often cited by papers focused on Medical Imaging Techniques and Applications (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Advanced Breast Cancer Therapies (3 papers). Sandra Sanabria collaborates with scholars based in United States, Colombia and Spain. Sandra Sanabria's co-authors include Richard Hargreaves, Christine Ryan, Waisi Eng, Terence G. Hamill, Stephen M. Krause, Shil Patel, Raymond E. Gibson, Kerry Riffel, Jeffrey Roppe and Céline Bonnefous and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Cancer Research.

In The Last Decade

Sandra Sanabria

28 papers receiving 447 citations

Peers

Countries citing papers authored by Sandra Sanabria

Since Specialization

Citations

This map shows the geographic impact of Sandra Sanabria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sanabria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sanabria more than expected).

Fields of papers citing papers by Sandra Sanabria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Sanabria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sanabria. The network helps show where Sandra Sanabria may publish in the future.

Co-authorship network of co-authors of Sandra Sanabria

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Sanabria. A scholar is included among the top collaborators of Sandra Sanabria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Sanabria. Sandra Sanabria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Community-Based Knowledge Translation Strategies for Maternal, Neonatal, and Perinatal Outcomes: A Systematic Review of Quantitative and Qualitative Data 2023 ·International Journal of Public Health ·Sandra Sanabria, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Catalina González-Uribe, (unknown), (unknown), Juan José Yepes-Núñez	1
2	Immunomodulatory, trypanocide, and antioxidant properties of essential oil fractions of Lippia alba (Verbenaceae) 2021 ·BMC Complementary Medicine and Therapies ·(unknown), (unknown), Sandra Milena Leal Pinto, Sandra Sanabria, Elena E. Stashenko, (unknown)	11
3	Rurality as an analytic category: implications for public health 2020 ·Revista de Salud Pública ·Sandra Sanabria	0
4	El desafío de los portadores asintomáticos de COVID-19: una revisión rápida de la literatura 2020 ·Revista de Salud Pública ·(unknown), J. Martín Rodríguez, (unknown), Sandra Sanabria	1
5	Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma 2019 ·Investigational New Drugs ·Shahneen Sandhu, Catriona M. McNeil, Patricia LoRusso, Manish R. Patel, Omar Kabbarah, Chunze Li, Sandra Sanabria, W. Michael Flanagan, Ru‐Fang Yeh, Flávia Brunstein, (unknown), Rodney J. Hicks, Vanessa Lemahieu, Raymond D. Meng, Omid Hamid, Jeffrey R. Infante	23
6	Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects 2016 ·Journal of Nuclear Medicine ·Olivier Barret, David Alagille, Sandra Sanabria, Robert A. Comley, Robby M. Weimer, Edilio Borroni, Mark A. Mintun, Nicholas Seneca, Caroline Papin, Thomas Morley, Kenneth Marek, John Seibyl, Gilles Tamagnan, Danna Jennings	53
7	Abstract PD5-2: Ph1b study of the PI3K inhibitor taselisib (GDC-0032) in combination with letrozole in patients with hormone receptor-positive advanced breast cancer 2015 ·Cancer Research ·Cristina Saura, Jasgit C. Sachdev, Manish R. Patel, Andrés Cervantes, Dejan Juric, Jeffrey R. Infante, Donald Richards, Sandra Sanabria, Xuyang Lu, Joseph A. Ware, Timothy R. Wilson, Hema Parmar, Jerry Y. Hsu, Mafalda Oliveira, Eric P. Winer, Daniel D. Von Hoff, José Baselga, Ian E. Krop	15
8	Mujer y desplazamiento de sí: sustratos socioculturales que soportan las redes de la violencia de género 2013 ·Revista de la Escuela Nacional de Salud Pública ·Sandra Sanabria, (unknown), (unknown)	0
9	Abstract PD1-3: Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer 2013 ·Cancer Research ·Dejan Juric, Cristina Saura, Andrés Cervantes, Carla Kurkjian, (unknown), Jasgit C. Sachdev, (unknown), IE Krop, Mafalda Oliveira, Sandra Sanabria, Sravanthi Cheeti, (unknown), (unknown), (unknown), Hema Parmar, (unknown), (unknown), José Baselga	11
10	PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy 2013 ·The Journal of Headache and Pain ·(unknown), Jan de Hoon, (unknown), Inge Derdelinckx, Kim Serdons, Guy Bormans, Tom Reynders, Ruben Declercq, Inge De Lepeleire, William P. Kennedy, Rebecca Blanchard, Eugene E. Marcantonio, Richard Hargreaves, Chi‐Chung Li, Sandra Sanabria, Eric D. Hostetler, Aniket Joshi, (unknown), Koen Van Laere	11
11	Occupancy of human brain GABAA receptors by the novel α5 subtype-selective benzodiazepine site inverse agonist α5IA as measured using [11C]flumazenil PET imaging 2010 ·Neuropharmacology ·Waisi Eng, John Atack, Mats Bergström, Sandra Sanabria, Lieuwe Appel, Gerard R. Dawson, David Sciberras, Richard Hargreaves, Bengt Långström, H. Donald Burns	15
12	Impacto y repercusión de 37 revistas de Enfermería del Espacio Científico Iberoamericano: Año 2008 2010 ·Index de Enfermería ·(unknown), Sandra Sanabria	1
13	Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18 2009 ·Synapse ·Terence G. Hamill, Nagaaki Sato, Makoto Jitsuoka, Shigeru Tokita, Sandra Sanabria, Waisi Eng, Christine Ryan, Stephen M. Krause, Norihiro Takenaga, Shil Patel, Zhizhen Zeng, David L. Williams, Cyrille Sur, Richard Hargreaves, H. Donald Burns	30
14	PET Imaging Studies in Rhesus Monkey with the Cannabinoid-1 (CB1) Receptor Ligand [11C]CB-119 2009 ·Molecular Imaging and Biology ·Terence G. Hamill, Linus S. Lin, William K. Hagmann, Ping Liu, James P. Jewell, Sandra Sanabria, Waisi Eng, Christine Ryan, Tung M. Fong, Brett Connolly, Amy Vanko, Richard Hargreaves, Mark T. Goulet, H. Donald Burns	10
15	Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans 2009 ·Journal of Pharmacology and Experimental Therapeutics ·John Atack, Dean F. Wong, Tim D. Fryer, Christine Ryan, Sandra Sanabria, Yun Zhou, Robert F. Dannals, (unknown), Raymond E. Gibson, H. Donald Burns, José M. Vega, (unknown), Paul Scott‐Stevens, John S. Beech, Jean‐Claude Baron, Bindi Sohal, Michael Schrag, Franklin I. Aigbirhio, Ruth M. McKernan, Richard Hargreaves	27
16	Quantification of HDAC inhibition by F-SAHA in rhesus monkey brain using the PET tracer [18F]FAHA 2008 ·NeuroImage ·Sandra Sanabria, Hong Fan, Kerry Riffel, Michael A. Williams, Christine Ryan, R.E. Gibson, Juri G. Gelovani, Jacquelynn J. Cook, Eric D. Hostetler	3
17	Brain CB-1 receptor occupancy of taranabant in lean subjects using CB-1R PET 2007 ·Diabetologia ·Inge De Lepeleire, Carol Addy, Paul Rothenberg, Donald Burns, Sandra Sanabria, Waisi Eng, Guy Bormans, Marleen Depré, Luc Mortelmans, Patrick Dupont, Aubrey Stoch, Keith Gottesdiener, Richard Hargreaves, (unknown), Koen Van Laere	1
18	PET imaging of neurokinin‐1 receptors with [¹⁸F]SPA‐RQ in human subjects: Assessment of reference tissue models and their test–retest reproducibility 2007 ·Synapse ·Fumihiko Yasuno, Sandra Sanabria, Donald Burns, Richard Hargreaves, Subroto Ghose, Masanori Ichise, Frederick T. Chin, Cheryl L. Morse, Victor W. Pike, Robert B. Innis	12
19	Gender and age affect NK1 receptors in the human brain – a positron emission tomography study with [18F]SPA-RQ 2006 ·The International Journal of Neuropsychopharmacology ·Mikko Nyman, Olli Eskola, Jaana Kajander, Tero Vahlberg, Sandra Sanabria, Donald Burns, Richard Hargreaves, Olof Solin, Jarmo Hietala	28
20	Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers 2005 ·Synapse ·Terence G. Hamill, Stephen M. Krause, Christine Ryan, Céline Bonnefous, (unknown), T. Jon Seiders, Nicholas D. P. Cosford, Jeffrey Roppe, Ted Kamenecka, Shil Patel, Raymond E. Gibson, Sandra Sanabria, Kerry Riffel, Waisi Eng, Christopher D. King, Xiaoqing Yang, Mitchell D. Green, Stacey O’Malley, Richard Hargreaves, H. Donald Burns	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact